Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Website: pfizer.com


  • Good financial results growth rate 12.3% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (4.4%)
  • Dividend yield for the last twelve months 6.7%
  • Free cash flow yield 10.8% (LTM)
  • Share price is 1.7% higher than minimum and 54.3% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (12.4x vs
    )
  • For the last 3 months insiders bought company shares on $0.4 mln (0.000% of cap.)

Key Financials (Download financials)

Ticker: PFE
Share price, USD:  (+0.8%)25.21
year average price 27.48  


year start price 27.75 2024-03-31

max close price 31.39 2024-07-30

min close price 24.80 2024-11-15

current price 25.21 2025-03-30
Common stocks: 5 615 000 000

Dividend Yield:  6.7%
FCF Yield LTM: 10.8%
EV / LTM EBITDA: 12.4x
EV / EBITDA annualized: 26.1x
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 141 554
Net Debt ($m): 44 168
EV (Enterprise Value): 185 722
EBITDA LTM ($m): 15 036
EV / LTM EBITDA: 12.4x
Price to Book: 1.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-03-26reuters.com

US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports

2025-03-25seekingalpha.com

Pfizer Is Trading As If It's 2009 Again

2025-03-24zacks.com

Pfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy?

2025-03-22seekingalpha.com

Pfizer: Bulls Need To Check Out Its Graham P/E

2025-03-20zacks.com

Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B

2025-03-20fool.com

3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025

2025-03-19reuters.com

Pfizer sells entire Haleon stake for $3.24 billion

2025-03-17barrons.com

Qualcomm CEO Is Set to Meet China's Xi. Pfizer and FedEx CEOs Are Also Heading to Beijing.

2025-03-13youtube.com

Calls of the Day: Invitation Homes, Pfizer and Roblox

2025-03-12businesswire.com

ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data